The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 20, 2022
Filed:
Jan. 09, 2020
Applicant:
Ignite Immunotherapy, Inc., New York, NY (US);
Inventors:
Douglas Hanahan, Saint-Sulpice, CH;
David H. Kirn, Mill Valley, CA (US);
Liliana Maruri Avidal, Oakland, CA (US);
Michael D. Eisenbraun, San Diego, CA (US);
Joseph J. Binder, San Diego, CA (US);
Clare Lees, Del Mar, CA (US);
Assignee:
Ignite Immunotherapy, Inc., New York, NY (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61P 31/00 (2006.01); A61P 35/00 (2006.01); A61K 39/395 (2006.01); C07K 16/28 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 39/001119 (2018.08); A61K 39/39558 (2013.01); A61P 31/00 (2018.01); A61P 35/00 (2018.01); C07K 16/2827 (2013.01); A61K 45/06 (2013.01); A61K 2039/5152 (2013.01);
Abstract
The present disclosure provides a replication-competent, recombinant oncolytic vaccinia virus; and compositions comprising the replication-competent, recombinant oncolytic vaccinia virus. The present disclosure also provides use of the vaccinia virus or composition for inducing oncolysis in an individual having a tumor.